4024 CapSure SP |
Product Characteristics | |||
|---|---|---|---|---|
| US Market Release | Oct-91 | Serial Number Prefix | LAJ | |
| Registered US Implants | 222,100 | Type and/or Fixation | Transvenous, Vent., Tines | |
| Estimated Active US Implants | 56,100 | Polarity | Bipolar | |
| Advisories | None | Steroid | Yes | |
| Ventricular Placement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| System Longevity Study Results |
|
|||||||||
| Number of Leads Enrolled in Study | 1,214 | |||||||||
| Cumulative Months of Follow-Up | 52,403 | |||||||||
| Number of Leads Active in Study | 23 | |||||||||
| Qualifying Complications | 3 Total | |||||||||
| Failure to Capture | 3 | |||||||||
